Trials / Sponsors / Walter K. Kraft
Walter K. Kraft
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Sirolimus in COVID-19 Phase 1 SARS-CoV-2, Covid-19 | Phase 1 | 2020-07-06 |
| Completed | Doravirine, Rifapentine and Isoniazid Interaction Latent Tuberculosis, Human Immunodeficiency Virus, Rifamycins Causing Adverse Effects in Therapeutic Use | Phase 1 | 2019-04-22 |